Announcements Trials
Browse Landscape

Status

Recruiting 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Prostatic Neoplasms 2Stress Disorders, Post-Traumatic 1Parkinson Disease 1Pain, Intractable 1Neoplasms 1Muscle Spasticity 1Multiple Sclerosis 1Inflammatory Bowel Diseases 1Huntington Disease 1Glaucoma 1Epilepsy 1Dyskinesias 1Chronic Disease 1Autism Spectrum Disorder 1Anemia, Sickle Cell 1Acquired Immunodeficiency Syndrome 1

Interventions

Gemcitabine 34pembrolizumab 27Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Registries × Clear all
NCT03886753 2020-07-30

Ilera

Children's Hospital of Philadelphia

Terminated
10 enrolled
Classical hematology

Autism Spectrum Disorder, Acquired Immunodeficiency Syndrome, Anemia, Sickle Cell, Epilepsy, Glaucoma, Huntington Disease, Multiple Sclerosis, Muscle Spasticity, Neoplasms, Pain, Intractable, Parkinson Disease, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Dyskinesias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡